The tumor stroma is no longer seen solely as physical support for mutated epithelial cells but as an important modulator and even a driver of tumorigenicity. Within the tumor stromal milieu, heterogeneous populations of fibroblast-like cells, collectively termed carcinoma-associated fibroblasts (CAFs), are key players in the multicellular, stromal-dependent alterations that contribute to malignant initiation and progression. This review focuses on novel insights into the contributions of CAFs to disease progression, emergent events leading to the generation of CAFs, identification of CAF-specific biomarkers predictive of disease outcome, and recent therapeutic approaches aimed at blunting or reverting detrimental protumorigenic phenotypes associated with CAFs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863733 | PMC |
| http://dx.doi.org/10.1101/gad.279737.116 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma.
Transl Oncol
January 2025
Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University (Second Military Medical University), 168 Changhai Road, Shanghai 200433, China. Electronic address:
Purpose The present study aimed to clarify the distribution pattern of carcinoma associated fibroblasts (CAFs) across pancreatic ductal adenocarcinoma (PDAC) and its prognostic prediction value. Methods Data of two cohorts were retrospectively collected from consecutive patients who underwent primary pancreatic resection from January 2015 to December 2017. We used tumor specimens to screen out the most suitable markers for the spatial distribution analysis for CAFs subpopulations.
View Article and Find Full Text PDFCAF-EVs carry lncRNA MAPKAPK5-AS1 into hepatocellular carcinoma cells and promote malignant cell proliferation.
Commun Biol
December 2024
The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Article Synopsis
- Hepatocellular carcinoma (HCC) is a serious cancer with a high risk of poor outcomes, and the lncRNA MAPKAPK5-AS1 is identified as an oncogene that aids in HCC cell growth.
- CAF-EVs (carcinoma-associated fibroblast-derived extracellular vesicles) deliver MAPKAPK5-AS1 to HCC cells, which inhibits SMURF2 and stabilizes TCF12, ultimately promoting HCC cell proliferation by upregulating FOXH1 expression.
- The study highlights potential new therapeutic targets for HCC treatment by demonstrating the role of CAF-EVs and MAPKAPK5-AS1 in tumor growth dynamics.
Carcinoma-Associated Fibroblasts Accelerate Growth and Invasiveness of Breast Cancer Cells in 3D Long-Term Breast Cancer Models.
Cancers (Basel)
November 2024
Department of Pharmacology, Wayne State University, Detroit, MI 48201, USA.
Article Synopsis
- Carcinoma-associated fibroblasts (CAFs) play a crucial role in fostering cancer progression by interacting with cancer cells within the tumor microenvironment, highlighting the potential for targeting CAF-driven pathways as a new cancer treatment strategy.
- A novel three-dimensional (3D) coculture model was developed to study the long-term interactions of triple-negative breast cancer (TNBC) cells and CAFs, which revealed important insights into their paracrine signaling over at least 70 days.
- The study demonstrated that TNBC spheroids in 3D coculture with CAFs showed increased invasiveness compared to those with normal fibroblasts, alongside preferential migration patterns, suggesting CAFs significantly enhance TNBC aggressive behaviors.
The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells.
MedComm (2020)
December 2024
Tumoural and Stromal Chemoresistance Group, Oncobell Program, IDIBELL L'Hospitalet de Llobregat Barcelona Catalonia Spain.
Colorectal liver metastases grow following different histologic growth patterns (HGPs), classified as desmoplastic and nondesmoplastic (dHGP, non-dHGP), being the latter associated with worst prognosis. This study aimed to investigate the tumor microenvironment (TME) between HGPs supporting different survival. Multiplexed immunohistochemical staining was performed with the Opal7 system in a 100-patients cohort to evaluate the tumor-liver interface with three different cell panels: lymphoid, myeloid, and carcinoma-associated fibroblasts.
View Article and Find Full Text PDFFAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study.
J Nucl Med
December 2024
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California;
Prostate-specific membrane antigen (PSMA) is a theranostic target for metastatic prostate cancer (PCa). However, castration-resistant PCa (CRPC) may lose PSMA expression after systemic therapy. Fibroblast activation protein (FAP), expressed by carcinoma-associated fibroblasts in various cancer types, including PCa, has the potential to be an alternative target.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!